Donanemab Clinical Use Growing in U.S., Rejected in Europe
Donanemab prescriptions have been slow to ramp up, but demand is growing due an easier dosing schedule than for lecanemab.
6585 RESULTS
Sort By:
Donanemab prescriptions have been slow to ramp up, but demand is growing due an easier dosing schedule than for lecanemab.
Healthy people who carry an autosomal-dominant AD mutation halved their odds of developing symptoms when they took gantenerumab for eight years.
Core structures of protofilaments from more diseases prompt an update to the family tree of tau filaments.
Dementia prevalence has come down nearly 3 percent per year for the last 40 years, with each successive birth cohort less likely to succumb.
In the largest study of its kind, volunteers took cognitive tests on their devices and had their app usage monitored. Baseline data flagged people with MCI.
People who ate a healthy diet and carried less abdominal fat in midlife had better-working brains 20 years later, according to MRI scans.
P-tau181 and p-tau217 are AD biomarkers, but they are also found in blood and muscles of people with ALS.
A large meta-analysis turns up 16 new loci.
Expression of TREM2, ApoE, and complement proteins correlated with extensive plaque clearance in response to Aβ immunotherapy.
Behold the first high-resolution structure of the human Parkinson’s-related kinase bound to mitochondrial membranes.
Meta-analysis of six longitudinal studies finds that, among people who are amyloid-positive, tau PET signal rose faster in women.
Inhibiting this receptor calmed reactive astrocytes and curbed their consumption of synapses in the hippocampus in a mouse amyloidosis model.
The largest single-cell RNA-Seq study of blood cells finds more sex-specific expression changes in PD than AD. The database is accessible online.
In rats, antibodies to the MTBR domain and adjacent C-terminal regions spared synaptic function.
Electronic health records show that various autoimmune disorders put people at higher risk for AD.
No filters selected